Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA WOMEN'S HEALTH, INC.”

19 pharma patents match "TEVA WOMEN'S HEALTH, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 19
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 19 pharmaceutical patents matching "TEVA WOMEN'S HEALTH, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

19 results for “TEVA WOMEN'S HEALTH, INC.” · 30,257 patents in full index Clear search

  1. US 9220692

    Methods of reducing symptoms in subjects using single dosage forms with tapering release rates

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  2. US 8980304

    Barrel-shaped vaginal ring

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  3. US 8680084

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  4. US 8663681

    Oral dosage forms comprising progesterone and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  5. US 8580293

    Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  6. US 8338396

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  7. US 8323679

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  8. US 8288342

    Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

    TEVA WOMEN'S HEALTH, INC. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  9. US 8247393

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  10. US 8226980

    Orally disintegrating solid dosage forms comprising progestin and methods of making and using thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  11. US 8217024

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  12. US 8202534

    Attachment of a handle to a solid oral dosage form

    TEVA WOMEN'S HEALTH, INC. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  13. US 8148560

    Vaginal tablets comprising misoprostol and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  14. US 7908729

    Method for making a lollipop

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted
  15. US 7910126

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted
  16. US 7858605

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted
  17. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  18. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  19. US 7772219

    Methods of hormonal treatment utilizing extended cycle contraceptive regimens

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted